Rentschler Biopharma SE

Rentschler Biopharma Appoints Former Bachem CCO Torsten Wöhr as CEO to Lead Next Growth Phase

- Rentschler Biopharma SE has appointed Dr. Torsten Wöhr as Chief Executive Officer, effective August 1, 2026, succeeding interim CEO Prof. Dr. Uwe Buecheler. - Dr. Wöhr brings over 25 years of international CDMO and biotechnology experience, most recently serving as Chief Commercial Officer at Bachem Group. - The appointment marks the next phase of the company's corporate strategy focused on long-term growth and sustainable value creation. - Prof. Dr. Uwe Buecheler will step down as interim CEO and resume his role as Vice Chairman of the Supervisory Board.